Wednesday - March 11, 2026
AAM and Biosimilars Council Laud FDA Plan to Streamline Biosimilar Medicines Development and Lower Costs for Patients
March 11, 2026
WASHINGTON, March 11 -- The Association for Accessible Medicines issued the following news release:

* * *

AAM and Biosimilars Council Laud FDA Plan to Streamline Biosimilar Medicines Development and Lower Costs for Patients

FDA draft guidance removes redundant PK testing requirements where scientifically rigorous data already exists

*

The Association for Accessible Medicines and its Biosimilars Council today lauded FDA updated guid . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products